Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · September 09, 2014

Rivaroxaban vs Warfarin in Patients With Non-Valvular Atrial Fibrillation

European Heart Journal

 

Additional Info

European Heart Journal
Clinical Characteristics and Outcomes With Rivaroxaban vs Warfarin in Patients With Non-Valvular Atrial Fibrillation but Underlying Native Mitral and Aortic Valve Disease Participating in the ROCKET AF Trial
Eur Heart J 2014 Aug 22;[EPub Ahead of Print], G Breithardt, H Baumgartner, SD Berkowitz, AS Hellkamp, JP Piccini, SR Stevens, Y Lokhnygina, MR Patel, JL Halperin, DE Singer, GJ Hankey, W Hacke, RC Becker, CC Nessel, KW Mahaffey, KAA Fox, RM Califf

Further Reading